Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Teva announces partnership with Lonza

Teva announces partnership with Lonza

20th January 2009

Teva has said it has established a joint venture with Lonza.

The company said a partnership will see the companies developing, manufacturing and marketing a number of generic equivalents of pharmaceutical products together.

Commenting on the collaboration, Shlomo Yanai, Teva president and chief executive officer, said the organisation had regarded biosimilars as a “major growth driver” for the business and the agreement would “bolster” such capabilities.

He added : “Lonza is an ideal partner for Teva in this field with its deep knowledge and experience in biopharmaceutical development, large scale manufacturing and state of the art manufacturing facilities.”

The deal is expected to commence during the first quarter of this year, though financial details have not been disclosed.

Last month, Teva said it had completed its acquisition of pharmaceutical company Barr.

As a result of the transaction, the combined company is expected to have a presence in over 60 countries.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.